Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Suliman Pharmaceutical Technology is a Chinese biotechnology and pharmaceutical research company founded in 2004 and headquartered in Beijing. The company specializes in the research and development of therapeutic formulations, including amino acid compositions, coenzyme preparations, and botanical derivatives such as asiatic acid. Its patent portfolio covers applications in cardiovascular and cerebrovascular diseases, male infertility, erectile dysfunction, depression, and liver protection. Beijing Suliman Pharmaceutical Technology primarily operates as an early-stage research and development entity, leveraging its proprietary formulations to address various chronic and metabolic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Suliman Pharmaceutical Technology.